BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23479335)

  • 1. Association between lipids, lipoproteins composition of HDL particles and triglyceride-rich lipoproteins, and LCAT and CETP activity in post-renal transplant patients.
    Kimak E; Bylina J; Solski J; Hałabiś M; Baranowicz-Gąszczyk I; Książek A
    Cell Biochem Biophys; 2013 Nov; 67(2):695-702. PubMed ID: 23479335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma.
    Murakami T; Michelagnoli S; Longhi R; Gianfranceschi G; Pazzucconi F; Calabresi L; Sirtori CR; Franceschini G
    Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1819-28. PubMed ID: 7583561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma phospholipid transfer protein, cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase in end-stage renal disease (ESRD).
    Pahl MV; Ni Z; Sepassi L; Moradi H; Vaziri ND
    Nephrol Dial Transplant; 2009 Aug; 24(8):2541-6. PubMed ID: 19297356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between serum lipid, lipoprotein, triglyceride-rich lipoprotein, and high-density lipoprotein particle concentrations in post-renal transplant patients.
    Kimak E; Hałabiś M; Baranowicz-Gaszczyk I
    J Zhejiang Univ Sci B; 2010 Apr; 11(4):249-57. PubMed ID: 20349521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities in growth hormone deficient and acromegalic men: role in altered high density lipoproteins.
    Beentjes JA; van Tol A; Sluiter WJ; Dullaart RP
    Atherosclerosis; 2000 Dec; 153(2):491-8. PubMed ID: 11164439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesteryl ester transfer protein (CETP), HDL capacity of receiving cholesterol and status of inflammatory cytokines in patients with severe heart failure.
    Martinelli AEM; Maranhão RC; Carvalho PO; Freitas FR; Silva BMO; Curiati MNC; Kalil Filho R; Pereira-Barretto AC
    Lipids Health Dis; 2018 Oct; 17(1):242. PubMed ID: 30342531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ApoE and apoC-III-defined HDL subtypes: a descriptive study of their lecithin cholesterol acyl transferase and cholesteryl ester transfer protein content and activity.
    Amaya-Montoya M; Pinzón-Cortés JA; Silva-Bermúdez LS; Ruiz-Manco D; Pérez-Matos MC; Jiménez-Mora MA; Mendivil CO
    Lipids Health Dis; 2020 May; 19(1):106. PubMed ID: 32450892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
    Chung BH; Segrest JP; Franklin F
    Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of vitamin E and HMG-CoA reductase inhibition on cholesteryl ester transfer protein and lecithin-cholesterol acyltransferase in hypercholesterolemia.
    Napoli C; Leccese M; Palumbo G; de Nigris F; Chiariello P; Zuliani P; Somma P; Di Loreto M; De Matteis C; Cacciatore F; Abete P; Liguori A; Chiariello M; D'Armiento FP
    Coron Artery Dis; 1998; 9(5):257-64. PubMed ID: 9710685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients.
    Kimak E; Ksiazek A; Baranowicz-Gaszczyk I; Solski J
    Ren Fail; 2007; 29(6):705-12. PubMed ID: 17763166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired suppression of plasma free fatty acids and triglycerides by acute hyperglycaemia-induced hyperinsulinaemia and alterations in high density lipoproteins in essential hypertension.
    Ligtenberg JJ; Van Tol A; Van Haeften TW; Sluiter WJ; Reitsma WD; Dullaart RP
    J Intern Med; 1996 Oct; 240(4):233-42. PubMed ID: 8918515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein subfraction profile and HDL-associated enzymes in sickle cell disease patients.
    Ozturk OH; Can Y; Yonden Z; Motor S; Oktay G; Kaya H; Aslan M
    Lipids; 2013 Dec; 48(12):1217-26. PubMed ID: 24113910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
    Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H
    Artery; 1993; 20(1):1-18. PubMed ID: 8447724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition.
    Kettunen J; Holmes MV; Allara E; Anufrieva O; Ohukainen P; Oliver-Williams C; Wang Q; Tillin T; Hughes AD; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT; Salomaa V; Järvelin MR; Perola M; Davey Smith G; Chaturvedi N; Danesh J; Di Angelantonio E; Butterworth AS; Ala-Korpela M
    PLoS Biol; 2019 Dec; 17(12):e3000572. PubMed ID: 31860674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic effects of a 24-hour intravenous triglyceride emulsion challenge on plasma lecithin: cholesterol acyltransferase, phospholipid transfer protein, and cholesteryl ester transfer protein activities.
    Riemens SC; Van Tol A; Sluiter WJ; Dullaart RP
    J Lipid Res; 1999 Aug; 40(8):1459-66. PubMed ID: 10428982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects.
    Lagrost L; Gandjini H; Athias A; Guyard-Dangremont V; Lallemant C; Gambert P
    Arterioscler Thromb; 1993 Jun; 13(6):815-25. PubMed ID: 8499401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Arg123-Tyr166 central domain of human ApoAI is critical for lecithin:cholesterol acyltransferase-induced hyperalphalipoproteinemia and HDL remodeling in transgenic mice.
    Holvoet P; De Geest B; Van Linthout S; Lox M; Danloy S; Raes K; Collen D
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):459-66. PubMed ID: 10669644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of insulin sensitivity and the TaqIB cholesteryl ester transfer protein gene polymorphism on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities and their response to hyperinsulinemia in non-diabetic men.
    Riemens SC; Van Tol A; Stulp BK; Dullaart RP
    J Lipid Res; 1999 Aug; 40(8):1467-74. PubMed ID: 10428983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of bezafibrate therapy on subfractions of plasma low-density lipoprotein and high-density lipoprotein, and on activities of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in patients with hyperlipoproteinemia.
    Homma Y; Ozawa H; Kobayashi T; Yamaguchi H; Sakane H; Mikami Y; Mikami Y; Nakamura H
    Atherosclerosis; 1994 Apr; 106(2):191-201. PubMed ID: 8060379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between moderately oxidized low-density lipoprotein and high-density lipoprotein particle subclass distribution in hemodialyzed and post-renal transplant patients.
    Kimak E; Hałabiś M; Baranowicz-Gąszczyk I; Solski J; Książek A
    J Zhejiang Univ Sci B; 2011 May; 12(5):365-71. PubMed ID: 21528490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.